Search results for

NPR justice correspondent Carrie Johnson tells host Kelly McEvers about the latest that's known about Wednesday's shooting in San Bernardino, Calif.

A Texas plumber who traded in his old F-250 pickup is suing the dealership because the truck ended up in Syria — in the hands of Islamist fighters, still emblazoned with the plumbing company decals.

Pete Rose will not be eligible for the Hall of Fame, at least for now. Major League Baseball announced Monday it was denying his plea for reinstatement. Rose received a lifetime ban from baseball in 1989 for betting on the game.

Dallas residents and community leaders react to the shootings of police officers during a rally and vigil Thursday evening.

The deadline to sign up for an Obamacare health insurance plan starting on Jan. 1 was extended until Friday because the web site was overwhelmed. Demand was up, but that might be because the penalties for not having insurance are increasing.

Princess Reema bint Bandar Al Saud has been pushing for women to have a greater sphere of influence in Saudi Arabia. Her hiring of women has helped shoppers get used to seeing women working in stores.

With the collapse of a two-year cease-fire, Turkish forces and Kurdish militants are again killing each other in earnest. In one largely Kurdish town, residents hunker down for more bloodshed.

NPR's Ari Shapiro interviews Brian Bennett, national security correspondent for the Los Angeles Times. He's been covering the investigation into the San Bernardino terrorism attack and tells us the latest known about the attackers.

The Republican presidential candidates are in Las Vegas for their latest debate, the first since terrorist attacks in Paris and California refocused the campaign on national security.

Despite striking ethnic disparities in the incidence and mortality of diseases like cancer and respiratory disease, minorities are not well represented in clinical trials. A paper out in the journal PLOS Medicine says two main barriers to achieving diverse clinical trials are the expense of recruiting minority subjects, and fears of exploitation in medical research.